The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 15.50
Low: 15.50
Prev. Close: 15.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Award, Trading Update, Notice of Results

22 Sep 2022 15:00

RNS Number : 3491A
Thruvision Group PLC
22 September 2022
 

 

22 September 2022

Thruvision Group plc

 

("Thruvision" or the "Company")

 

Contract Award, Trading Update, Notice of Results

 

Thruvision (AIM: THRU), the specialist provider of people-screening technology to the international security market, is pleased to announce a contract award, trading update and notice on the timing of publication for its full year results for the year ended 31 March 2022.

The Company has been awarded a further contract, totalling $2.7 million, to complete the process of upgrading US Customs and Border Protection's (CBP) existing fleet of Thruvision 8-channel units to the latest 16-channel variant, running Thruvision's AI detection algorithm. This latest contract, awarded via Thruvision's US Government contracting partner, is a follow-on order to the one received in the second half of FY22 and is in line with the Company's expectations for FY23.

As reported in our trading update in April 2022, we supported CBP in deploying its existing units to the US Southern Border to enable it to manage the very high levels of migration. This close engagement has proven the significant value our solution provides, both in terms of seizures of drugs and cash, and the very positive feedback from front-line officers. Our April trading update also stated that CBP had made public its intentions to purchase additional "passive pedestrian scanners". We have high confidence that this process will commence imminently, leading to further revenue in the second half of FY23.

Our other key market is retail Profit Protection, where the economic situation has obviously become more challenging for retailers since our April update. Trading in the current financial year to date has been consistent with the same period in FY22. Sales activity levels are also consistent with last year as we head into our historically busiest period for order intake.

Existing Profit Protection customers, who now fully appreciate the in-year return on their investment from deploying Thruvision technology, continue to expand and upgrade their Thruvision fleets. In particular, we are seeing strong interest in our latest "walk-through" lane which we pioneered with Next PLC. The lane uses two cameras and our AI algorithm to significantly increase the throughput rate, allowing 100% employee screening, thereby maximising deterrence and very materially reducing levels of theft.

Our focus on Third-Party Logistics providers (3PLs) which operate significant numbers of distribution centres has also delivered further success. In addition to CEVA, we have added a second major global 3PL, which is headquartered in Germany. This customer has placed an initial order for a dual-camera walk-through lane for a high-profile site in the UK and we now expect to sign a global supply framework with them. We are also discussing further Thruvision deployments over the next few months with this customer.

We expect to publish our full year results for the year ended 31 March 2022 in the last week of September 2022. This is somewhat later than usual and is due to significant delays in the audit process this year because of resourcing issues and a significantly higher degree of scrutiny throughout the process.

 

For further information please contact:

 

Thruvision Group plc

Colin Evans, Chief Executive

Tom Black, Executive Chairman

+44 (0)1235 436180

Investec Bank plc

James Rudd / Patrick Robb / Sebastian Lawrence

+44 (0)20 7597 5970

 

FTI Consulting LLP

Matt Dixon / Tom Blundell

+44 (0)20 3727 1000

About Thruvision

Thruvision is the leading provider of safe distance, people security screening technology. Using patented passive terahertz technology, Thruvision is uniquely capable of detecting metallic and non-metallic threats including weapons, explosives and contraband items that are hidden under clothing, at distances between 3m and 10m. Addressing the growing need for safe, fast and effective security, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation and transportation security, retail supply chain loss prevention, facilities and public area protection and customs and border control. The company has offices near Oxford, and Washington DC.

www.thruvision.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEADNAADAAEFA
Date   Source Headline
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results
2nd Apr 20207:40 amRNSTrading Statement
25th Nov 20197:00 amRNSInterim Results
19th Nov 20197:00 amRNSNotice of Interim Results
13th Nov 20193:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.